Publications
Found 1 results
Filters: Author is S. Tekes [Clear All Filters]
“The insertion/deletion polymorphism in the ACE gene and chronic obstructive pulmonary disease”, vol. 12, pp. 1392-1398, 2013.
, Ahsan A, Ram R, Baig MA and Pasha MA (2004). ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin. Biochem. 37: 1037-1040.
http://dx.doi.org/10.1016/j.clinbiochem.2004.05.026
PMid:15498534
Bayram B, Kilicci C, Onlu H, Ozkurt M, et al. (2011). Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS). Gene 489: 86-88.
http://dx.doi.org/10.1016/j.gene.2011.08.012
PMid:21939743
Berdeli A and Cam FS (2009). Prevalence of the angiotensin I converting enzyme gene insertion/deletion polymorphism in a healthy Turkish population. Biochem. Genet. 47: 412-420.
http://dx.doi.org/10.1007/s10528-009-9240-8
PMid:19390959
Borzyszkowska J, Stanislawska-Sachadyn A, Wirtwein M, Sobiczewski W, et al. (2012). Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels. J. Appl. Genet. 53: 175-182.
http://dx.doi.org/10.1007/s13353-012-0083-3
PMid:22307319 PMCid:3334489
Brice EA, Friedlander W, Bateman ED and Kirsch RE (1995). Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD. Chest 107: 706-710.
http://dx.doi.org/10.1378/chest.107.3.706
PMid:7874941
Busquets X, MacFarlane NG, Heine-Suner D, Morla M, et al. (2007). Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2: 329-334.
PMid:18229571 PMCid:2695206
Domingues-Montanari S, Fernandez-Cadenas I, del Rio-Espinola A, Mendioroz M, et al. (2010). The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals. Eur. J. Neurol. 17: 1390-1392.
PMid:20402757
Gurkan A, Emingil G, Saygan BH, Atilla G, et al. (2009). Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis. Arch. Oral Biol. 54: 337-344.
http://dx.doi.org/10.1016/j.archoralbio.2008.12.005
PMid:19162259
Harry RG, Herman-Jan P, Ann Emil MWJS, Nicholas SH, et al. (2004). ACE gene polymorphism in COPD. Am. J. Respir. Crit. Care Med. 170: 572-573.
Hocher B, Schlemm L, Haumann H, Jian L, et al. (2011). Offspring sex determines the impact of the maternal ACE I/D polymorphism on maternal glycaemic control during the last weeks of pregnancy. J. Renin-Angiotensin-Aldosterone Syst. 12: 254-261.
http://dx.doi.org/10.1177/1470320310387843
PMid:21393357
Hopkinson NS, Nickol AH, Payne J, Hawe E, et al. (2004). Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170: 395-399.
http://dx.doi.org/10.1164/rccm.200304-578OC
PMid:15117739
Indrajaya T (2011). The role of ACE gene polymorphism on pathogenesis of ischemic stroke. Acta Med. Indones. 43: 152-157.
PMid:21979279
Kanazawa H, Okamoto T, Hirata K and Yoshikawa J (2000). Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162: 1235-1238.
http://dx.doi.org/10.1164/ajrccm.162.4.9909120
PMid:11029323
Kanazawa H, Otsuka T, Hirata K and Yoshikawa J (2002). Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 121: 697-701.
http://dx.doi.org/10.1378/chest.121.3.697
PMid:11888948
Lee J, Nordestgaard BG and Dahl M (2009). Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity. Respir. Med. 103: 1286-1292.
http://dx.doi.org/10.1016/j.rmed.2009.04.003
PMid:19423314
MacNee W (2005). Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2: 50-60.
http://dx.doi.org/10.1513/pats.200411-056SF
PMid:16113469
Mak JC (2008). Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int. J. Tuberc. Lung Dis. 12: 368-374.
PMid:18371260
Marc D, Janssens W and Miravitles M (2012). Chronic obstructive pulmonary disease. Semin. Lancet. 379: 1341-1351.
http://dx.doi.org/10.1016/S0140-6736(11)60968-9
Miller MR, Crapo R, Hankinson J, Brusasco V, et al. (2005a). General considerations for lung function testing. Eur. Respir. J. 26: 153-161.
http://dx.doi.org/10.1183/09031936.05.00034505
PMid:15994402
Miller MR, Hankinson J, Brusasco V, Burgos F, et al. (2005b). Standardisation of spirometry. Eur. Respir. J. 26: 319-338.
http://dx.doi.org/10.1183/09031936.05.00034805
PMid:16055882
Namazi S, Monabati A, Ardeshir-Rouhani-Fard S and Azarpira N (2010). Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian population. Mol. Carcinog. 49: 1022-1030.
http://dx.doi.org/10.1002/mc.20685
PMid:20945417
Pabst S, Theis B, Gillissen A, Lennarz M, et al. (2009). Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease. Eur. J. Med. Res. 4 (Suppl 14): 177-181.
Rigat B, Hubert C, Corvol P and Soubrier F (1992). PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20: 1433.
http://dx.doi.org/10.1093/nar/20.6.1433-a
PMid:1313972 PMCid:312213
Selahaddin T, Birgul I, Tekin Y and Selda S (2010). Chronic Obstructive Pulmonary Disease and Paraoxonase-1 192 and 55 Gene Polymorphisms. Biotechnol. Biotechnol. 24: 1644-1647.
http://dx.doi.org/10.2478/V10133-010-0019-1
Tkacova R, Joppa P, Stancak B, Salagovic J, et al. (2005). The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD. Wien. Klin. Wochenschr. 117: 210-214.
http://dx.doi.org/10.1007/s00508-005-0333-z
PMid:15875760
Ucar G, Yildirim Z, Ataol E, Erdogan Y, et al. (1997). Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters. Life Sci. 61: 1075-1082.
http://dx.doi.org/10.1016/S0024-3205(97)00616-4
Ueda S, Heeley RP, Lees KR, Elliott HL, et al. (1996). Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. J. Mol. Endocrinol. 17: 27-30.
http://dx.doi.org/10.1677/jme.0.0170027
PMid:8863184
Yakut T, Karkucak M, Ursavas A, Gulten T, et al. (2010). Lack of association of ACE gene I/D polymorphism with obstructive sleep apnea syndrome in Turkish patients. Genet. Mol. Res. 9: 734-738.
http://dx.doi.org/10.4238/vol9-2gmr755
PMid:20449805
Yaren A, Turgut S, Kursunluoglu R, Oztop I, et al. (2006). Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J. Exp. Med. 210: 109- 116.
http://dx.doi.org/10.1620/tjem.210.109
PMid:17023764
Yaren A, Turgut S, Kursunluoglu R, Oztop I, et al. (2007). Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors. J. Investig. Med. 55: 255-261.
http://dx.doi.org/10.2310/6650.2007.00006
PMid:17850737
Zhang X, Wang C, Dai H, Lin Y, et al. (2008). Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology 13: 683-688.
http://dx.doi.org/10.1111/j.1440-1843.2008.01325.x
PMid:18713090
Zhang Y, He J, Deng Y, Zhang J, et al. (2011). The insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme gene and cancer risk: a meta-analysis. BMC Med. Genet. 12: 159.
http://dx.doi.org/10.1186/1471-2350-12-159
PMid:22151803 PMCid:3254074